Details for Patent: 8,470,871
✉ Email this page to a colleague
Which drugs does patent 8,470,871 protect, and when does it expire?
Patent 8,470,871 protects AKLIEF and is included in one NDA.
This patent has twenty-seven patent family members in twenty-three countries.
Summary for Patent: 8,470,871
| Title: | Ligands that modulate RAR receptors |
| Abstract: | Novel ligand compounds having the general formula (I): ##STR00001## and pharmaceutical/cosmetic compositions comprised thereof are useful in human and veterinary medicine or, alternatively, in cosmetics. |
| Inventor(s): | Biadatti; Thibaud (Opio, FR), Dumais; Laurence (Le Rouret, FR), Soulet; Catherine (Antibes, FR), Talano; Sandrine (Vence, FR), Daver; Sebastien (Antibes, FR) |
| Assignee: | Galderma Research & Development (Biot, FR) |
| Application Number: | 13/527,299 |
|
Patent Claim Types: see list of patent claims | Use; |
Drugs Protected by US Patent 8,470,871
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Galderma Labs Lp | AKLIEF | trifarotene | CREAM;TOPICAL | 211527-001 | Oct 4, 2019 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | METHOD OF ACTIVATING RARGAMMA RECEPTOR | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
Foreign Priority and PCT Information for Patent: 8,470,871
| Foriegn Application Priority Data | ||
| Foreign Country | Foreign Patent Number | Foreign Patent Date |
| France | 04/13848 | Dec 23, 2004 |
International Family Members for US Patent 8,470,871
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| European Patent Office | 1831149 | ⤷ Sign Up | 301042 | Netherlands | ⤷ Sign Up |
| European Patent Office | 1831149 | ⤷ Sign Up | CA 2020 00027 | Denmark | ⤷ Sign Up |
| European Patent Office | 1831149 | ⤷ Sign Up | 122020000029 | Germany | ⤷ Sign Up |
| European Patent Office | 1831149 | ⤷ Sign Up | LUC00162 | Luxembourg | ⤷ Sign Up |
| European Patent Office | 1831149 | ⤷ Sign Up | 2020C/525 | Belgium | ⤷ Sign Up |
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
